Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PWWP domain-containing protein 2B (PWWP2B) is a nuclear chromatin-binding protein characterized by its PWWP domain, an approximately 70 amino acid motif mediating protein-protein and protein-DNA/histone interactions. It forms a variant NuRD complex that modulates histone acetylation at actively transcribed genes and affects transcription elongation via RNA polymerase II. PWWP2B also plays a crucial role in DNA double-strand break repair, being rapidly recruited to damage sites through interactions with UHRF1 and MRE11, facilitating homologous recombination and genome integrity. Mutations in the gene are recurrent in gastric adenocarcinoma and associated with poor outcomes, implicating PWWP2B in cancer biology and genome stability. The function of PWWP2B as a chromatin modifier and DNA repair factor highlights its relevance in transcriptional regulation, thermogenesis, and disease pathophysiology.
Not applicable—no current drugs directly target PWWP2B
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PWWP domain-containing protein 2B (PWWP2B).